Carl Zeiss Meditec AG
CZMWF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | -1.20 | 0.16 | -0.88 |
| FCF Yield | 5.82% | 0.00% | 0.00% | -0.65% |
| EV / EBITDA | 17.34 | 87.15 | 56.06 | 108.30 |
| Quality | ||||
| ROIC | 2.87% | 0.00% | 1.73% | 0.00% |
| Gross Margin | 71.92% | 52.71% | 53.88% | 51.40% |
| Cash Conversion Ratio | 2.51 | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 7.75% | 1.58% | 2.38% | 1.98% |
| Free Cash Flow Growth | 0.00% | 0.00% | 100.00% | -169.73% |
| Safety | ||||
| Net Debt / EBITDA | 0.46 | 0.00 | 1.19 | 0.00 |
| Interest Coverage | 9.98 | 8.25 | 10.16 | 4.06 |
| Efficiency | ||||
| Inventory Turnover | 1.31 | 0.00 | 0.47 | 0.00 |
| Cash Conversion Cycle | 113.85 | 0.00 | 221.37 | 0.00 |